Alere Medical, Inc. Sustainability Profile
Alere Medical, Inc., a prominent player in the healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in 1998, the company has established itself as a leader in point-of-care diagnostics, focusing on innovative solutions that enhance patient care and streamline clinical workflows. Alere's core offerings include rapid diagnostic tests and monitoring devices, which are distinguished by their accuracy and speed, enabling healthcare professionals to make informed decisions swiftly. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that bolster its market position. With a commitment to advancing medical technology, Alere Medical continues to be a trusted name in the diagnostics sector, recognised for its contributions to improving patient outcomes globally.
DitchCarbon Score
How does Alere Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alere Medical, Inc.'s score of 80 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alere Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes UnitedHealth Group Incorporated, from which it inherits climate-related commitments and performance metrics. As a merged entity, Alere Medical's climate initiatives and reduction targets are aligned with those of UnitedHealth Group. However, specific reduction targets or achievements for Alere Medical itself have not been disclosed. The company does not appear to have set Science-Based Targets Initiative (SBTi) reduction targets or other documented climate pledges. In the context of climate commitments, Alere Medical is expected to adhere to the sustainability and emissions reduction strategies established by its parent company, UnitedHealth Group. This includes a focus on reducing emissions across various scopes, although specific details regarding these initiatives have not been provided for Alere Medical. Overall, while Alere Medical, Inc. does not present its own emissions data or reduction targets, it is positioned within a larger framework of corporate responsibility and climate action through its relationship with UnitedHealth Group.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Alere Medical, Inc.'s Industry?
How Carbon Intensive is Alere Medical, Inc.'s Location?
Alere Medical, Inc.'s Scope 3 Categories Breakdown
Alere Medical, Inc.'s Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Alere Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alere Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
